Gendius is headed up by Rory Cameron (CEO) an experienced pharmaceutical and mHealth leader who has built and exited successful companies. Rory is passionate to ensure that Gendius operates at the highest ethical standards.

Co-founder Chris Genders is also a seasoned pharmaceutical industry professional, operating to director level. The original idea for intellin came from Chris's diagnosis of diabetes 15 years ago, and his passion is use mHealth and technology to help those with diabetes live better and understand their condition.

Chair Albert Nicholl has many years of experience in med tech industry and now spends his time as a coach and mentor for entrepreneurs. Further Board advisors include Charles Toomey, James Crossland and Dr Natasha Patel.

The motivation comes from a personal experience of just how hard diabetes can be. Many apps exist that tell you how you've been doing (the rear-view mirror) while intellin helps you understand the road ahead (sat-nav).

intellin has been proven as a capable remote monitoring platform and has been rated on the NHS backed Orcha platform which has driven greater engagement during the Covid crisis. Post COVID, we aim to develop the concept even further working alongside not only the NHS but private providers too.

We believe the current pandemic has identified the need for remote management of people with diabetes. Intellin is that solution.